Last reviewed · How we verify

NCT06789523: FB-WWUM

Friendship Bench for Women Who Use Methamphetamine in Vietnam

Recruiting now NA Last updated 8 August 2025
What this trial tests

NA trial testing Friendship Bench in Methamphetamine Use in 100 participants. Currently enrolling.

Timeline
11 June 2025
Primary endpoint
31 December 2028
31 August 2029

Quick facts

Lead sponsorHanoi Medical University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment100
Start date11 June 2025
Primary completion31 December 2028
Estimated completion31 August 2029
Sites1 location across Vietnam

Drugs / interventions tested

Conditions studied

Sponsor

Hanoi Medical University

Who can join

18 and older, female only, with Methamphetamine Use or Common Mental Disorders (CMD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The high comorbidity of mental health issues and meth use in women worsens both their mental health and meth use outcomes. The study team proposes to evaluate the potential of Friendship Bench to be used as a low-threshold, task-shifting mental health intervention among women who use methamphetamine in Vietnam - a lower-middle-income country. The study will provide preliminary data for a R01 trial testing the effectiveness Friendship Bench to improve mental health and methamphetamine use outcomes among women who use methamphetamine in Vietnam.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Methamphetamine Use

Currently open trials in the same condition.

Other Hanoi Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06789523.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing